Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

ARL-15849KF: a selective CCK-A agonist for the treatment of eating disorders

March 18, 1998

Spironolactone and Diane 35 may have synergistic effects in hirsutism

March 18, 1998

FDA advisory committee reaches a stand-off on orlistat recommendation

March 16, 1998

More antiobesity proteins emerge from Lilly research

March 16, 1998

Gene therapies for obesity revealed by Merck & Co., Baylor College of Medicine

March 16, 1998

The association between neuropathy and microcirculation in diabetic foot ulcers

March 16, 1998

Lilly enters genomics alliance for type II diabetes and obesity research

March 13, 1998

INVICORP shows 70% efficacy in ED study

March 13, 1998

FDA approves low-dose Estratab for osteoporosis

March 13, 1998

Risedronate: a potential nonhormonal agent for the prevention of osteoporosis

March 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...